May 25, 2020

May 22, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
23
Sep
FDA Proposes Revisions to the Proposed Foreign Supplier Verification Rule Covington & Burling LLP
23
Sep
Energy & Environmental Law Update -- September 22, 2014 Mintz
23
Sep
Biomarin Pharmaceutical Inc. v. Duke University: Authorizing Opposition to Motion to Exclude IPR2013-00535 Faegre Drinker
22
Sep
Guilty Convictions in Salmonella Trial May Signify Landmark in Criminal Food-Safety Prosecutions Mintz
22
Sep
FDA Issues Revisions to Proposed Food Safety Rules, Reopens Comment Period for Revisions Only Barnes & Thornburg LLP
22
Sep
White House Mobilizes Forces Against Superbug Covington & Burling LLP
22
Sep
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series Michael Best & Friedrich LLP
22
Sep
Major Damages Award in Pelvic Mesh Case Underscores the Critical Role of Internal Email in Jury Trials Covington & Burling LLP
20
Sep
Court Rejects FDA’s Interpretation of the Statute’s Device Definition as “Erroneous and Unreasonable” Covington & Burling LLP
19
Sep
DEA Controlled Substance Disposal Requirements Take Effect October 9, 2014 Beveridge & Diamond PC
19
Sep
Internet/Social Media Platforms: FDA Draft Guidance Giordano, Halleran & Ciesla, P.C.
16
Sep
President Obama’s Response to the Ebola Crisis Covington & Burling LLP
15
Sep
340B Federal Drug Pricing Program September Update: Self-Disclosures McDermott Will & Emery
13
Sep
Judge Requires PhRMA To Initiate New 340B Orphan Drug Lawsuit to Challenge Interpretive Rule Covington & Burling LLP
13
Sep
Looking Towards the Future of Pharmaceuticals in Africa Covington & Burling LLP
12
Sep
National Institute of Standards and Technology (NIST) Issues Draft Report Enumerating Risks and Protections to Consider When Evaluating Mobile Apps for Your Enterprise Mintz
11
Sep
FutureGen Receives EPA Permits for Underground Injection Greenberg Traurig, LLP
11
Sep
FDA Focuses on Sex-Specific Data in Medical Device Clinical Trials Covington & Burling LLP
11
Sep
FDA Publishes “Purple Book” for Biologicals/Biosimilars Schwegman, Lundberg & Woessner, P.A.
11
Sep
Indefiniteness After The Supreme Court Nautilus Decision – A Very “Delicate Balance” Schwegman, Lundberg & Woessner, P.A.

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Wednesday, June 24, 2020